Safety &amp; Efficacy of Direct Acting Antiviral (Sofosbuvir &amp; Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

Safety & Efficacy of Direct Acting Antiviral (Sofosbuvir & Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

M.A Mohamed, H.S Alegaily + Show 1 more

Open Access

https://doi.org/10.21608/bjas.2022.221164

Copy DOI

Publication Date: Jan 1, 2022

Safety & Efficacy of Direct Acting Antiviral (Sofosbuvir & Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

Full Text

Paper version not known

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author